Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis
Condition(s):Multiple SclerosisLast Updated:August 23, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:August 23, 2018Completed
Condition(s):Bone Marrow Fibrosis; Myeloproliferative NeoplasmLast Updated:October 11, 2023Withdrawn
Condition(s):Bone Marrow TransplantLast Updated:November 30, 2018Completed
Condition(s):Bone Marrow EdemaLast Updated:August 9, 2018Terminated
Condition(s):Osteonecrosis of the Femoral Head; Avascular Necrosis of the Femoral HeadLast Updated:March 21, 2024Not yet recruiting
Condition(s):UlcerLast Updated:April 30, 2018Terminated
Condition(s):Hematopoietic and Lymphoid System NeoplasmLast Updated:December 21, 2023Recruiting
Condition(s):Type 1 Diabetes MellitusLast Updated:March 20, 2012Completed
Condition(s):Sensorineural Hearing LossLast Updated:March 18, 2022Suspended
Condition(s):OsteoarthritisLast Updated:December 14, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.